These indicate that methylation‐associated silencing of TFPI2 plays a causal role in advanced tumor phenotypes of high‐methylation MM, which results in thicker progression, worse prognosis, and reportedly, metastasis through increasing cellular growth and invasion. The gene discussed is TFPI2; the disease is Miyoshi myopathy.